Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte(®) Platform

The practice of medicine has steadily employed less invasive methods to obtain information derived from the tumor to guide clinical management of patients. Liquid biopsy—the sampling of blood—is a non-invasive method for generating information previously only available from tissue biopsies of the tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaldjian, Eric P., Ramirez, Arturo B., Costandy, Lillian, Ericson, Nolan G., Malkawi, Walla I., George, Thaddeus C., Kasi, Pashtoon Murtaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927801/
https://www.ncbi.nlm.nih.gov/pubmed/35308236
http://dx.doi.org/10.3389/fphar.2022.835727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927801/
https://www.ncbi.nlm.nih.gov/pubmed/35308236
http://dx.doi.org/10.3389/fphar.2022.835727

Ejemplares similares